Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 2
2005 1
2006 3
2009 2
2010 1
2013 4
2014 1
2015 7
2016 8
2017 6
2018 7
2019 3
2020 5
2021 7
2022 8
2023 16
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Management of inflammatory bowel disease.
Wright EK, Ding NS, Niewiadomski O. Wright EK, et al. Among authors: ding ns. Med J Aust. 2018 Sep 1;209(7):318-323. doi: 10.5694/mja17.01001. Med J Aust. 2018. PMID: 30257634 Review.
Vedolizumab for induction and maintenance of remission in Crohn's disease.
Hui S, Sinopoulou V, Gordon M, Aali G, Krishna A, Ding NS, Boyapati RK. Hui S, et al. Among authors: ding ns. Cochrane Database Syst Rev. 2023 Jul 17;7(7):CD013611. doi: 10.1002/14651858.CD013611.pub2. Cochrane Database Syst Rev. 2023. PMID: 37458279 Free PMC article. Review.
ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease.
Noor NM, Sousa P, Bettenworth D, Gomollón F, Lobaton T, Bossuyt P, Casanova MJ, Ding NS, Dragoni G, Furfaro F, van Rheenen PF, Chaparro M, Gisbert JP, Louis E, Papamichail K. Noor NM, et al. Among authors: ding ns. J Crohns Colitis. 2023 Jul 5;17(7):1031-1045. doi: 10.1093/ecco-jcc/jjad001. J Crohns Colitis. 2023. PMID: 36626338 Free article.
Letter: diagnostic delay in inflammatory bowel disease.
Tassone D, Gilmore R, Lee T, Ding NS. Tassone D, et al. Among authors: ding ns. Aliment Pharmacol Ther. 2023 May;57(10):1203-1204. doi: 10.1111/apt.17483. Aliment Pharmacol Ther. 2023. PMID: 37094304 No abstract available.
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial.
Schulberg JD, Wright EK, Holt BA, Hamilton AL, Sutherland TR, Ross AL, Vogrin S, Miller AM, Connell WC, Lust M, Ding NS, Moore GT, Bell SJ, Shelton E, Christensen B, De Cruz P, Rong YJ, Kamm MA. Schulberg JD, et al. Among authors: ding ns. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):318-331. doi: 10.1016/S2468-1253(21)00393-9. Epub 2021 Dec 8. Lancet Gastroenterol Hepatol. 2022. PMID: 34890567 Clinical Trial.
76 results